Skip to content

MRI BASED HYPERTHERMIA TREATMENT PLANNING An Investigation in Women with Cervical Cancer

MRI BASED HYPERTHERMIA TREATMENT PLANNING An Investigation in Women with Cervical Cancer - MRI based treatment planning

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42811
Enrollment
40
Registered
2016-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Forty women with newly diagnosed inoperable cervical cancer will receive the standard MRI (40 min) plus experimental protocol (20 min). Twenty women who will receive primary radiotherapy (plus standard chemotherapy or hyperthermia) will also receive extension with 2 standard MRIs required for treatment monitoring during radiotherapy (40 min) with the experimental protocol (~20 min).

Exclusion criteria

Exclusion criteria: • Inability of the patient to provide informed consent or legally incompetent/incapacitated to do so, • Presence of metal in the body (e.g. osteosynthetic material, pacemaker, artificial cardiac valves), • Claustrophobia • Pregnancy • Previous adversary reaction to Gadovist-i.v. contrast

Design outcomes

Primary

MeasureTime frame
Assessment of electric tissue properties and perfusion in patients with cervical cancer by MRI, and the variation in corresponding distribution during the course of radiotherapy (plus chemotherapy or hyperthermia).

Secondary

MeasureTime frame
None.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)